Loading…

Respiratory pathology in the Optn-/- mouse model of Amyotrophic Lateral Sclerosis

•The optineurin-deficient mouse model (Optn-/-) exhibits respiratory insufficiency during a hypoxic and hypercapnic challenge.•Motor neuron loss is evident in the hypoglossal motor nucleus of 12 months old Optn-/- mice.•The hypoglossal and phrenic nerves of Optn-/- mice demonstrate dysmyelination as...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory physiology & neurobiology 2020-11, Vol.282, p.103525-103525, Article 103525
Main Authors: McCall, Angela L., Dhindsa, Justin S., Pucci, Logan A., Kahn, Amanda F., Fusco, Anna F., Biswas, Debolina D., Strickland, Laura M., Tseng, Henry C., ElMallah, Mai K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The optineurin-deficient mouse model (Optn-/-) exhibits respiratory insufficiency during a hypoxic and hypercapnic challenge.•Motor neuron loss is evident in the hypoglossal motor nucleus of 12 months old Optn-/- mice.•The hypoglossal and phrenic nerves of Optn-/- mice demonstrate dysmyelination as evidenced by disorganized and frayed myelin.•An accumulation of mitochondria in hypoglossal nerve axons occurs in the absence of optineurin. Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder that results in death due to respiratory failure. Many genetic defects are associated with ALS; one such defect is a mutation in the gene encoding optineurin (OPTN). Using an optineurin null mouse (Optn-/-), we sought to characterize the impact of optineurin deficiency on respiratory neurodegeneration. Respiratory function was assessed at 6 and 12 mo of age using whole body plethysmography at baseline during normoxia (FiO2: 0.21; N2 balance) and during a respiratory challenge with hypoxia and hypercapnia (FiCO2: 0.07, FiO2: 0.10; N2 balance). Histological analyses to assess motor neuron viability and respiratory nerve integrity were performed in the medulla, cervical spinal cord, hypoglossal nerve, and phrenic nerve. Minute ventilation, peak inspiratory flow, and peak expiratory flow are significantly reduced during a respiratory challenge in 6 mo Optn-/-mice. By 12 mo, tidal volume is also significantly reduced in Optn-/- mice. Furthermore, 12mo Optn-/- mice exhibit hypoglossal motor neuron loss, phrenic and hypoglossal dysmyelination, and accumulated mitochondria in the hypoglossal nerve axons. Overall, these data indicate that Optn-/- mice display neurodegenerative respiratory dysfunction and are a useful model to study the impact of novel therapies on respiratory function for optineurin-deficient ALS patients.
ISSN:1569-9048
1878-1519
DOI:10.1016/j.resp.2020.103525